Summit Therapeutics shares owned by Credit Suisse
Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Credit Suisse
from 13F filings
Historical chart of Credit Suisse investment in Summit Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Summit Therapeutics held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Summit Therapeutics by Credit Suisse
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $283k | 108k | 2.61 |
| 2023-09-30 | $209k | 112k | 1.87 |
| 2023-06-30 | $299k | 119k | 2.51 |
| 2022-06-30 | $0 | 14 | 0.00 |